# Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection

> **NCT07435649** · NA · NOT_YET_RECRUITING · sponsor: **Delve Bio, Inc.** · enrollment: 400 (estimated)

## Conditions studied

- Central Nervous System Infection

## Interventions

- **DIAGNOSTIC_TEST:** Delve Detect CSF mNGS Test
- **OTHER:** Real-World Data

## Key facts

- **NCT ID:** NCT07435649
- **Lead sponsor:** Delve Bio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435649, "Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT07435649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*